Ticker Details
Adaptive Biotechnologies Corporation
IPO Date:	June 24, 2019
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$2.34B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.60 | 3.26%
Avg Daily Range (30 D):	$0.45 | 2.58%
Avg Daily Range (90 D):	$0.46 | 2.75%

Institutional Daily Volume
Avg Daily Volume:	1.11M
Avg Daily Volume (30 D):	1.58M
Avg Daily Volume (90 D):	1.86M

Trade Size
Avg Trade Size (Sh.):	90
Avg Trade Size (Sh.) (30 D):	66
Avg Trade Size (Sh.) (90 D):	72

Institutional Trades
Total Institutional Trades:	2,884
Avg Institutional Trade:	$1.96M
Avg Institutional Trade (30 D):	$3.18M
Avg Institutional Trade (90 D):	$2.63M
Avg Institutional Trade Volume:	.11M
Avg Institutional Trades (Per Day):	2

Market Closing Trades
Avg Closing Trade:	$2.46M
Avg Closing Trade (30 D):	$4.36M
Avg Closing Trade (90 D):	$4.21M
Avg Closing Volume:	150.1K

News

Dec 15, 2025 @ 5:31 PM Pfizer Faces Another Quiet Year As Patent Losses C... Source: Vandana Singh

Dec 6, 2025 @ 1:30 PM Adaptive Biotechnologies Showcases Leadership in H... Source: Adaptive Biotechnologies Corporation

Dec 5, 2025 @ 6:33 PM Why Is Adaptive Biotechnologies Stock Trading Lowe... Source: Vandana Singh

Aug 6, 2025 @ 11:01 PM Why Adaptive Biotechnologies Stock Popped by Almos... Source: Eric Volkman

Jul 25, 2025 @ 8:59 AM U.S. Minimal Residual Disease Testing Market Trend... Source: Researchandmarkets.Com

Financials
	TTM	Q3 2025	Q2 2025
Basic EPS		$.06	$-.17
Diluted EPS		$.06	$-.17
Revenue		$93.97M	$58.88M
Gross Profit		$75.82M	$40.88M
Net Income / Loss		$9.55M	$-25.59M
Operating Income / Loss		$10.29M	$-25.04M
Cost of Revenue		$18.16M	$18M
Net Cash Flow		$11.84M	$-7.47M
PE Ratio